COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02657356
Recruitment Status : Terminated (Exposure of these high-risk patients to clinic or in-person visits during the pandemic presented an unacceptable risk to their health)
First Posted : January 15, 2016
Last Update Posted : May 18, 2020
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 7, 2020
Actual Study Completion Date : May 7, 2020